-------- Original Version -----------
Oculis announces positive FDA Pre-IND feedback supporting Privosegtor development strategy for treatment of acute multiple sclerosis relapses.-------- English Version ------------
Oculis announces positive FDA Pre-IND feedback supporting Privosegtor development strategy for treatment of acute multiple sclerosis relapses.-------- Link if available ----------